| Prof Michael Good AO & Dr Danielle Stanisic |
| Griffith University |
| Malaria |
| Vaccine |
Key outcomes:
- Collaborating with industry and currently in clinical trials
- Signed an agreement with Statens Serum Institute to provide material for the pre-clinical animal studies
- Leveraged over $1m from Rotary Australia to support clinical trial costs of the study
- Clinical trial has received additional funding of $500,000 from Medical Research Future Fund Accelerated Research initiative
- Private trust funding, $570,000
- Private philanthropic donor, $372,027
- Griffith University funding, $334,968
“The funding provided by NFMRI specifically supported the GMP-compliant manufacturing of the vaccine and enabled additional leveraging of funding from Rotary to support the clinical trial activities as well as additional funding from the Medical Research Future Fund Accelerated Research initiative to enable further optimisation and development of a field-deployable vaccine, suitable for malaria endemic areas.”